Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International, Non-randomised, Non-interventional, Multicentre Study to Identify and Characterise Patients With CKD and High Proteinuria for Possible Participation in Future Renal Clinical Studies.

NCT05967806 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05967806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05967806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International, Non-randomised, Non-interventional, Multicentre Study to Identify and Characterise Patients With CKD and High Proteinuria for Possible Participation in Future Renal Clinical Studies.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 31, 2023
Completion date
August 30, 2024
Enrollment
2,575 (actual)
Sites
80

Conditions

As the registry lists them; a condition with its own page is linked.

renal disease